Literature DB >> 19219626

Hyperthermia induced NFkappaB mediated apoptosis in normal human monocytes.

Natarajan Aravindan1, Karthigayan Shanmugasundaram, Mohan Natarajan.   

Abstract

Conceptual approaches of heat-induced cytotoxic effects against tumor cells must address factors affecting therapeutic index, i.e., the relative toxicity for neoplastic versus normal tissues. Accordingly, we investigated the effect of hyperthermia treatment (HT) on the induction of DNA fragmentation, apoptosis, cell-cycle distribution, NFkappaB mRNA expression, DNA-binding activity, and phosphorylation of IkappaBalpha in the normal human Mono Mac 6 (MM6) cells. For HT, cells were exposed to 43 degrees C. FACS analysis showed a 48.5% increase in apoptosis, increased S-phase fraction, and reduced G2 phase fraction after 43 degrees C treatments. EMSA analysis showed a dose-dependent inhibition of NFkappaB DNA-binding activity after HT. This HT-mediated inhibition of NFkappaB was persistent even after 48 h. Immunoblotting analysis revealed dose-dependent inhibition of IkappaBalpha phosphorylation. Similarly, RPA analysis showed that HT persistently inhibits NFkappaB mRNA. These results demonstrate that apoptosis upon HT exposure of MM6 cells is regulated by IkappaBalpha phosphorylation mediated suppression of NFkappaB.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19219626     DOI: 10.1007/s11010-009-0039-z

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  39 in total

Review 1.  Status of clinical hyperthermia.

Authors:  O Dahl; R Dalene; B C Schem; O Mella
Journal:  Acta Oncol       Date:  1999       Impact factor: 4.089

2.  Death by dozens of cuts.

Authors:  M Barinaga
Journal:  Science       Date:  1998-04-03       Impact factor: 47.728

3.  Local microwave hyperthermia in treatment of advanced prostatic adenocarcinoma.

Authors:  S Szmigielski; H Zielinski; B Stawarz; J Gil; J Sobczynski; G Sokolska; J Jeljaszewicz; G Pulverer
Journal:  Urol Res       Date:  1988

4.  Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group.

Authors:  J van der Zee; D González González; G C van Rhoon; J D van Dijk; W L van Putten; A A Hart
Journal:  Lancet       Date:  2000-04-01       Impact factor: 79.321

5.  Scanned focussed ultrasound hyperthermia: initial clinical results.

Authors:  D S Shimm; K H Hynynen; D P Anhalt; R B Roemer; J R Cassady
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-11       Impact factor: 7.038

Review 6.  Rationale for use of local hyperthermia with radiation therapy and selected anticancer drugs in locally advanced human malignancies.

Authors:  T S Herman; B A Teicher; M Jochelson; J Clark; G Svensson; C N Coleman
Journal:  Int J Hyperthermia       Date:  1988 Mar-Apr       Impact factor: 3.914

7.  Radiation induced G1-block and p53 status in six human cell lines.

Authors:  F Zölzer; S Hillebrandt; C Streffer
Journal:  Radiother Oncol       Date:  1995-10       Impact factor: 6.280

8.  A phase I-II trial of cisplatin, hyperthermia and radiation in patients with locally advanced malignancies.

Authors:  T S Herman; M S Jochelson; B A Teicher; P J Scott; J Hansen; J R Clark; M R Pfeffer; L E Gelwan; B J Molnar-Griffin; S M Fraser
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-12       Impact factor: 7.038

9.  Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology.

Authors:  J Overgaard; D Gonzalez Gonzalez; M C Hulshof; G Arcangeli; O Dahl; O Mella; S M Bentzen
Journal:  Lancet       Date:  1995-03-04       Impact factor: 79.321

10.  Inhibition of I kappaB-alpha phosphorylation at serine and tyrosine acts independently on sensitization to DNA damaging agents in human glioma cells.

Authors:  J Miyakoshi; K Yagi
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

View more
  2 in total

1.  BAG3 protects against hyperthermic stress by modulating NF-κB and ERK activities in human retinoblastoma cells.

Authors:  Tatsuya Yunoki; Yoshiaki Tabuchi; Atsushi Hayashi; Takashi Kondo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-12-04       Impact factor: 3.117

2.  Irreversible EGFR inhibitor EKB-569 targets low-LET γ-radiation-triggered rel orchestration and potentiates cell death in squamous cell carcinoma.

Authors:  Natarajan Aravindan; Charles R Thomas; Sheeja Aravindan; Aswathi S Mohan; Jamunarani Veeraraghavan; Mohan Natarajan
Journal:  PLoS One       Date:  2011-12-29       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.